Drug
D0254 | Buthionine sulfoximine (BSO)
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Warning |
Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure Respiratory tract irritation] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 2-Amino-4-(S-butylsulfonimidoyl)butanoic acid | 2-Amino-4-(butylsulfonimidoyl);butanoic acid | 2-Amino-4-(butylsulfonimidoyl)butanoic acid |
| 2-Amino-4-(butylsulfonimidoyl)butanoic acid # | 2-amino-4-(S-butylsulfonimidoyl)butyric acid | 2-amino-4-[butyl(imino)oxo-??-sulfanyl]butanoic acid |
| 5072-26-4 | 71765-30-5 | AKOS022106364 |
| API0009406 | AS-67962 | B 2640 |
| BCP24029 | BCP27775 | BRD-A04020513-001-01-9 |
| BRN 2367136 | BSO | BSPBio_002464 |
| BUTHIONINE SULFOXIMINE | Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)- | Buthione sulfoximine |
| Buthionine sulfoxamine | Buthionine sulphoximine | Buthionine-S,R-sulfoximine |
| Buthionine-S,R-sulfoximine, L- | Butionine sulfoximine | C04543 |
| C8H18N2O3S | CCG-204326 | CHEBI:28714 |
| CHEMBL1256575 | CHEMBL1627290 | CS-0025687 |
| CTK8F8906 | D,L-Buthionine-(S,R)-sulfoximine | D,L-Buthionine-(S,R)-sulfoximine (Synonyms: Butionine sulfoximine) |
| DB12870 | DL-Buthionine (S,R)-sulfoximine, 99% | DL-Buthionine-(S,R)-sulfoximine |
| DL-Buthionine-S,R-sulfoximine | DL-Buthionine-[S,R]-sulfoximine | DL-Buthionine-sulfoximine |
| DL-Buthionine-sulfoximine, >=99.0% (TLC) | DL-butathionine-(S,R)-sulfoximine | DTXSID6044434 |
| EU-0100231 | FT-0624379 | HMS3260P03 |
| HY-106376 | KJQFBVYMGADDTQ-UHFFFAOYSA-N | KS-000018ET |
| L-Buthionine (SR)-sulfoximine | L-Buthionine-(S,R)-sulphoximine | LP00231 |
| LS-46081 | LS-46082 | Lopac0_000231 |
| MCULE-8178742509 | MFCD00070309 | NCGC00015148-03 |
| NCGC00015148-04 | NCGC00015148-05 | NCGC00015148-06 |
| NCGC00015148-07 | NCGC00093696-01 | NCGC00093696-02 |
| NCGC00093696-03 | NCGC00260916-01 | NCI60_002827 |
| NSC 326231 | NSC 381100 | NSC-381100 |
| NSC326231 | NSC381100 | OR9025T |
| Q5002519 | S-Butyl-DL-homocysteine-[S,R]-sulfoximine | S-butyl-DL-homocysteine (S,R)-sulfoximine |
| SCHEMBL62033 | SPECTRUM1505108 | SR-01000075713 |
| SR-01000075713-1 | ST51012445 | STL328818 |
| Sulfoximine, S-(3-amino-3-carboxypropyl)-S-butyl- | Tox21_500231 | ZX-AT019574 |
| dl-buthionine (s,r)-sulfoximine |
| DrugBank Name | Buthionine Sulfoximine |
| DrugBank | DB12870 |
| CAS Number | 113158-69-3, 5072-26-4, 71765-30-5, 83730-53-4 |
| PubChem Compound | 21157 |
| KEGG Compound ID | C04543 |
| PubChem.Substance | 347829028 |
| ChEBI | 28714 |
| ChemSpider | 19896 |
| Wikipedia | Buthionine sulfoximine |